论文部分内容阅读
本文作者对印尼政府的三种结核病治疗方案进行比较。第一种结核病治疗方案为现行的方案即35%短期疗程(利福平、异烟肼、乙胺丁醇联合用药)与65%标准疗程(链霉素、异烟肼、吡嗪酰胺联合用药)。第二种治疗方案是由100%标准疗程法组成的标准疗程方案。第三种治疗方案是由100%短期疗程法组成的短期疗程方案。结果显示,短期疗程方案在减少结核杆菌阳性人群的患病率方面取得了最佳效益。20年内,该方案使结核杆菌阳性人群减少了65%,而现行的方案和标准方案分别减少了52%和45%,如果从1980年起,由短
The authors compare the three tuberculosis treatment options for the Indonesian government. The first treatment program for tuberculosis consisted of 35% of the current regimen (rifampicin, isoniazid, ethambutol in combination) and 65% of the standard regimen (streptomycin, isoniazid, pyrazinamide ). The second treatment is a standard treatment regimen consisting of 100% standard treatment. The third treatment is a short course of treatment consisting of 100% short course of treatment. The results show that the short-term treatment program to reduce the prevalence of Mycobacterium tuberculosis positive rate has made the best benefit. Within 20 years, the program reduced the number of Mycobacterium tuberculosis positive people by 65%, while the current programs and standard programs were reduced by 52% and 45% respectively. If from 1980,